GlycoMimetics 8-K Shows Pfizer Said Ongoing Phase 3 Trial With Rivipansel Is ~75% Enrolled, Pfizer Delayed Timeline For Complete Enrollment From 2H'18 To Early 2019, Top-Line Data Available From End OF 2018 To Q2'19

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!